AI
ONCY

Atom Investors’s Oncolytics Biotech ONCY Stock Holding History

Atom Investors’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,257
Closed -$10.9K – 609
2024
Q1 		$10.9K Buy
+10,257
New +$11.5K ﹤0.01% 562

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Atom Investors's ONCY Position: Q2 2024 in Review

Atom Investors sold out of Oncolytics Biotech (ONCY) in Q2 2024, closing a stake of 10,257 shares — an estimated $10.9K sold.

Atom Investors first reported a position in ONCY in Q1 2024 and held it in 1 quarter. The position peaked at $10.9K in Q1 2024. 41 funds tracked by Wall St. Rank hold ONCY as of Q2 2024.

  • Atom Investors reported no remaining Oncolytics Biotech position as of Q2 2024 after selling out during the quarter.
  • Atom Investors sold 10,257 Oncolytics Biotech shares in Q2 2024, an estimated $10.9K.
  • Atom Investors first reported a position in Oncolytics Biotech in Q1 2024 and held it in 1 quarter.
  • Atom Investors's Oncolytics Biotech position peaked at $10.9K in Q1 2024.
  • 41 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2024.

Based on Atom Investors's 13F filing for Q2 2024, filed 14 Aug 2024.